A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

Clinical trial NCT03083665 · COMPLETED

Trial details

NCT number: NCT03083665
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Partial Seizures With or Without Secondary Generalization Epilepsy

Start date: 2017-08-22
Primary completion: 2022-06-30
Enrollment: 449

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.